TrialAmerican journal of nephrology2013

Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

John R Montford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.